Funder: Dept. of the Army -- USAMRAA
Due Dates: July 22, 2025 (Pre-Application/LOI) | August 26, 2025 (Full Application)
Funding Amounts: Up to $140,000 total costs (direct + indirect) per award; max 2 years; ~17 awards; $2.38M total program funding.
Summary: Supports high-risk, innovative, and untested research concepts in rare cancers; preliminary data not required; strict blinded review.
Key Information: Applications must not identify the PI, collaborators, or institutions anywhere in the proposal narrative or supporting documents.